The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)
To access this article, please choose from the options below
PII: S0959-8049(05)00346-1
doi:10.1016/j.ejca.2005.03.027
© 2005 Elsevier Ltd. All rights reserved.
